Chicoutimi, Canada Clinical Trials

A listing of Chicoutimi, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 79 clinical trials
TALAPRO-3: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, STUDY OF TALAZOPARIB WITH ENZALUTAMIDE VERSUS PLACEBO WITH ENZALUTAMIDE IN MEN WITH DDR GENE MUTATED METASTATIC CASTRATION-SENSITIVE PROSTATE CANCER

The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalutamide in participants with DDR-deficient mCSPC.

CIUSSS- saguenay-Lac-Saint-Jean
 (6.5 away) Contact site
  • 0 views
  • 20 Sep, 2022
  • +205 other locations
Phase III Radium 223 mCRPC-PEACE III (PEACE III)

The primary objective of the trial is to assess if upfront combination of enzalutamide and Ra223 improves radiological progression-free survival (rPFS1) compared to enzalutamide single agent in CRPC patients metastatic to bone

adenocarcinoma of prostate
bilateral orchidectomy
neutrophil count
metastasis
gonadotropin
Centre De Sante Et De Services Sociaux De Chicoutimi
 (6.5 away) Contact site
  • 514 views
  • 03 Jul, 2022
  • +61 other locations
My Choices: Efficacy and Implementation Study

The aim of the study is to assess the efficacy of the My Choices - Alcohol program by comparing alcohol-use of people before and after doing the program to people that did not do the program on the same period of time (3 months).

Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay-Lac-Saint-Jean
 (6.1 away) Contact site
  • 0 views
  • 15 Jul, 2022
  • +3 other locations
Effects of a 12-week Strength Training Program in Women With Myotonic Dystrophy Type 1

20 women with myotonic dystrophy type 1 (DM1) will complete a 12-week lower-limb strength training program. The training program consist of 3 series of 6 to 8 maximal repetitions of 5 different exercises: Leg extension, leg press, hip abduction, squat and plantar flexion. Training sessions will be closely supervise and …

myotonic dystrophy
Groupe de recherche interdisciplinaire sur les maladies neuromusculaires
 (6.3 away) Contact site
  • 0 views
  • 20 Jun, 2022
  • 1 location
A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension (KARDIA-1) (KARDIA-1)

The purpose of this study is to evaluate the effect of ALN-AGT01 on systolic and diastolic blood pressure and to characterize the pharmacodynamic (PD) effects and safety of ALN-AGT01.

systolic blood pressure
antihypertensive drugs
hypertension
Clinical Trial Site
 (6.6 away) Contact site
  • 40 views
  • 26 Jul, 2022
  • +71 other locations
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1, Followed by an Open-Label Extension

The primary objective of this study is to evaluate the safety and efficacy of pitolisant compared with placebo in treating excessive daytime sleepiness (EDS) in patients with Myotonic Dystrophy Type 1 ages 18 to 65 years. The secondary objectives of this study are to assess the impact of pitolisant on …

drug test
respiratory assessment
myotonic dystrophy
Hôpital de Chicoutimi
 (3.6 away) Contact site
  • 0 views
  • 18 Sep, 2022
  • +15 other locations
Phenotypes, Biomarkers and Pathophysiology in Spastic Ataxias (SPAX-PBP)

The aim of this study is to determine the clinical spectrum and natural progression of Spastic Ataxias (SPAX) and related disorders in a prospective multicenter natural history study, identify digital, imaging and molecular biomarkers that can assist in diagnosis and therapy development and study the genetic etiology and molecular mechanisms …

Accepts healthy volunteers
Université de Sherbrooke
 (6.3 away) Contact site
  • 0 views
  • 29 May, 2022
  • +7 other locations
SHARED Study (Saguenay Hospitals Anaphylaxis Rule for Early Discharge) (SHARED)

Anaphylaxis is a potentially fatal condition with a prevalence between 0.05 and 2% in the general population. This is therefore a frequent reason for emergency visits. Its diagnosis is mainly based on the NIAID / FAAN2 criteria, developed in 2006. The treatment of the condition consists of administration of intramuscular …

Service d'urgence CIUSSS du Saguenay - Lac-St-Jean
 (6.5 away) Contact site
  • 0 views
  • 30 May, 2022
  • 1 location
The Predictive Value of Coexisting TMPRSS2-ERG Gene Fusion and PTEN Deletion in Prostate Cancer Patients With Biochemical Failure Status Post Salvage or Radical Radiation Therapy

The objective of the study is to evaluate the predictive value of TMPRSS2-ERG gene fusion and PTEN in patients with high risk prostate cancer treated with first line LHRH agonist after biochemical failure.

gonadorelin
luteinizing hormone-releasing hormone agonist
PTEN
CIUSSS du Saguenay-Lac-St-Jean/CSSS de Chicoutimi
 (6.5 away) Contact site
  • 12 views
  • 23 Feb, 2022
  • +7 other locations